Stocks Overview

LAST PRICE
2.3500
TODAY'S CHANGE (%)
Trending Up0.1200 (5.3812%)

Bid / Lots
2.2500/ 3
Ask / Lots
2.4000/ 51
Open / Previous Close
2.2700 / 2.2300
Day Range
Low 2.2500
High 2.4000
52 Week Range
Low 0.6300
High 2.4100
Volume
730,320
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 2.23
Time	Volume	CRDL
09:32 ET	6957	2.27
09:36 ET	500	2.266
09:38 ET	100	2.27
09:39 ET	19435	2.28
09:43 ET	3367	2.2901
09:45 ET	6420	2.29
09:48 ET	2130	2.32
09:52 ET	1011	2.32
09:54 ET	800	2.32
09:56 ET	1500	2.33
09:57 ET	2165	2.31
09:59 ET	2743	2.28
10:06 ET	4270	2.34
10:08 ET	1298	2.34
10:10 ET	905	2.34
10:12 ET	4669	2.3499
10:14 ET	1000	2.34
10:15 ET	1300	2.34
10:17 ET	48373	2.35
10:19 ET	44223	2.35
10:21 ET	8691	2.33
10:24 ET	1335	2.34
10:28 ET	800	2.33
10:30 ET	3361	2.335
10:32 ET	700	2.34
10:35 ET	2600	2.34
10:37 ET	11600	2.36
10:39 ET	26809	2.39
10:42 ET	28774	2.37
10:44 ET	6600	2.37
10:46 ET	500	2.36
10:48 ET	2800	2.36
10:50 ET	1142	2.36
10:53 ET	1323	2.3594
10:55 ET	1605	2.36
11:06 ET	11750	2.36
11:09 ET	13641	2.36
11:11 ET	400	2.36
11:15 ET	400	2.36
11:20 ET	5158	2.36
11:24 ET	100	2.36
11:26 ET	200	2.36
11:27 ET	1308	2.37
11:29 ET	200	2.36
11:33 ET	100	2.36
11:36 ET	352	2.368
11:38 ET	100	2.36
11:40 ET	300	2.37
11:42 ET	10500	2.37
11:44 ET	13283	2.38
11:45 ET	500	2.3781
11:47 ET	600	2.378
11:49 ET	12294	2.3797
11:51 ET	495	2.38
11:54 ET	200	2.3799
11:56 ET	900	2.37
11:58 ET	1000	2.375
12:00 ET	1109	2.37
12:03 ET	100	2.37
12:05 ET	300	2.37
12:09 ET	100	2.37
12:14 ET	500	2.375
12:16 ET	10439	2.37
12:18 ET	7649	2.37
12:20 ET	2438	2.365
12:21 ET	100	2.36
12:23 ET	6717	2.35
12:30 ET	2400	2.34
12:32 ET	2450	2.34
12:34 ET	3055	2.34
12:36 ET	3600	2.34
12:38 ET	14879	2.34
12:52 ET	2750	2.3595
12:54 ET	140	2.35
01:03 ET	230	2.355
01:06 ET	100	2.3599
01:10 ET	250	2.3534
01:14 ET	5300	2.35
01:15 ET	3033	2.34
01:24 ET	127	2.3485
01:30 ET	200	2.34
01:33 ET	100	2.34
01:35 ET	451	2.3487
01:51 ET	400	2.3363
01:57 ET	200	2.34
02:00 ET	2900	2.34
02:02 ET	1000	2.3499
02:09 ET	400	2.34
02:15 ET	669	2.34
02:26 ET	1709	2.3426
02:27 ET	100	2.33
02:29 ET	169	2.3415
02:31 ET	200	2.33
02:33 ET	500	2.3394
02:36 ET	6058	2.3101
02:40 ET	7289	2.3101
02:42 ET	8579	2.315
02:44 ET	2111	2.3174
02:49 ET	960	2.3199
02:51 ET	2819	2.3206
02:56 ET	100	2.33
02:58 ET	500	2.3201
03:00 ET	300	2.33
03:02 ET	1476	2.3395
03:03 ET	200	2.335
03:05 ET	1950	2.3357
03:09 ET	1350	2.34
03:12 ET	2288	2.34
03:16 ET	1250	2.34
03:18 ET	1340	2.3393
03:20 ET	1200	2.3367
03:21 ET	12805	2.33
03:23 ET	6980	2.33
03:25 ET	15500	2.33
03:27 ET	44387	2.34
03:30 ET	58216	2.3325
03:32 ET	2805	2.33
03:34 ET	2200	2.33
03:36 ET	56696	2.34
03:38 ET	3567	2.33
03:39 ET	13927	2.34
03:41 ET	3200	2.34
03:43 ET	900	2.34
03:45 ET	11000	2.34
03:48 ET	5235	2.35
03:50 ET	900	2.34
03:52 ET	10689	2.33
03:54 ET	2085	2.335
03:56 ET	2000	2.35
03:57 ET	548	2.34
03:59 ET	6928	2.35

Data delayed at least 15 minutes.

May 23, 2024
- DJ Cardiol Therapeutics Inc. Price Target Raised to $8.00/Share From $6.00 by Canaccord Genuity, from 11:48AM ET on Thursday May 23, 2024 by Dow Jones
  11:48AM ET on Thursday May 23, 2024 by Dow Jones
- DJ Cardiol Therapeutics Is Maintained at Buy by Canaccord Genuity, from 8:08AM ET on Thursday May 23, 2024 by Dow Jones
  8:08AM ET on Thursday May 23, 2024 by Dow Jones
May 14, 2024
- DJ Cardiol Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co., from 11:10AM ET on Tuesday May 14, 2024 by Dow Jones
  11:10AM ET on Tuesday May 14, 2024 by Dow Jones
- Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024, from 7:33AM ET on Tuesday May 14, 2024 by Dow Jones
  7:33AM ET on Tuesday May 14, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCRDL Cardiol Therapeutics Inc	209.1M	0.0x	---
As of 2024-05-25

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

Contact Information

Headquarters: 602-2265 Upper Middle Road EastOAKVILLE, ON, Canada L6H 0G5
Phone: 289-910-0850
Fax: 905-491-6793

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$209.1M
Revenue (TTM)	$0.00
Shares Outstanding	68.4M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.60
EPS	$-0.46
Book Value	$0.43
P/E Ratio	0.0x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Cardiol Therapeutics Inc
NASDAQ:CRDLUnited StatesView on Canadian Exchange

Search Criteria

Charts

Recent News

May 23, 2024

DJ Cardiol Therapeutics Inc. Price Target Raised to $8.00/Share From $6.00 by Canaccord Genuity, from 11:48AM ET on Thursday May 23, 2024 by Dow Jones

DJ Cardiol Therapeutics Is Maintained at Buy by Canaccord Genuity, from 8:08AM ET on Thursday May 23, 2024 by Dow Jones

May 14, 2024

DJ Cardiol Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co., from 11:10AM ET on Tuesday May 14, 2024 by Dow Jones

Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024, from 7:33AM ET on Tuesday May 14, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar